BODART V ET AL: "Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4", BIOCHEMICAL PHARMACOLOGY, ELSEVIER, US, vol. 78, no. 8, 15 October 2009 (2009-10-15), pages 993-1000, XP026562697, ISSN: 0006-2952, DOI: 10.1016/J.BCP.2009.06.010 [retrieved on 2009-06-18] (B1)

WO-A2-2009/094456 (B1)

Burixafor Medkoo Datasheet. http://www.medkoo.com/products/7600 (B1)

DAVID T. CHUNG ET AL.: "TG-0054, a Novel and Potent Stem Cell Mobilizer, Displays Excellent PK/PD and Safety Profile in Phase I Trial", BLOOD, vol. 114, no. 22, 866, 20 November 2009 (2009-11-20), page 357, (B1)

DE CLERCQ ET AL: "Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil(TM)) and potential of other CXCR4 antagonists as stem cell mobilizers", PHARMACOLOGY AND THERAPEUTICS, ELSEVIER, GB, vol. 128, no. 3, 1 December 2010 (2010-12-01), pages 509-518, XP027445817, ISSN: 0163-7258, DOI: 10.1016/J.PHARMTHERA.2010.08.009 [retrieved on 2010-10-26] (B1)

Keiichi Muramatsu ET AL: "Prolonged survival of experimental extremity allografts: A new protocol with total body irradiation, granulocyte-colony stimulation factor, and FK506", Journal of Orthopaedic Research, 1 January 2009 (2009-01-01), pages n/a-n/a, XP055110337, ISSN: 0736-0266, DOI: 10.1002/jor.21011 (B1)

Kirsten E Herbert ET AL: "The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution", EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 10, no. 1, 1 December 2009 (2009-12-01), pages 113-125, XP055463000, ASHLEY, LONDON; GB ISSN: 1471-2598, DOI: 10.1517/14712590903473123 (B1)

METTE M. ROSENKILDE ET AL.: "Molecular mechanism of action of Monocyclam versus Bicyclam non-peptide antagonists in the CXCR4 chemokine receptorNR- 37", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 37, 14 September 2007 (2007-09-14), pages 27354-27365, (B1)

Margarit C; Rimola A; Gonzalez-Pinto I; Cuervas-Mons V; Edo A; Andreu H; Moreno-Gonzalez E; Calleja J L: "Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation", TRANSPLANT INTERNATIONAL., vol. 11, no. Suppl. 1, 5 June 1998 (1998-06-05), pages S260-S266, XP055110273, GB ISSN: 0934-0874, DOI: 10.1007/s001470050474 (B1)

PENTO J T: "FK-506", DRUGS OF THE FUTURE, PROUS SCIENCE, ES, vol. 14, no. 8, 1 January 1989 (1989-01-01), pages 746-752, XP009170678, ISSN: 0377-8282 (B1)

S.L. DAVIES ET AL: "Plerixafor Hydrochloride", DRUGS OF THE FUTURE, vol. 32, no. 2, 1 January 2007 (2007-01-01), page 123, XP055068423, ISSN: 0377-8282, DOI: 10.1358/dof.2007.032.02.1071897 (B1)

T. OKABAYASHI ET AL: "Mobilization of Host Stem Cells Enables Long-Term Liver Transplant Acceptance in a Strongly Rejecting Rat Strain Combination", AMERICAN JOURNAL OF TRANSPLANTATION, vol. 11, no. 10, 30 August 2011 (2011-08-30), pages 2046-2056, XP055068421, ISSN: 1600-6135, DOI: 10.1111/j.1600-6143.2011.03698.x (B1)

Tocris AMD 3465 hexahydrobromide - Certificate of Analysis Print date 14.01.2016 (B1)

US-A1- 2008 009 495 (B1)

Bruno K. Podesser ET AL: "Comparison of Low and High Initial Tacrolimus Dosing in Primary Heart Transplant Recipients: A Prospective European Multicenter Study", Transplantation, vol. 79, no. 1, 15 January 2005 (2005-01-15), pages 65-71, XP055110272, GB ISSN: 0041-1337, DOI: 10.1097/01.TP.0000140965.83682.D6 (B1)